Clinical trial
A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung…
NCT00346645 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Terminated
Key facts
| NCT number | NCT00346645 |
|---|---|
| Title | A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer |
| Official title | A Phase II Study of Velcade® (Bortezomib) in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Chemotherapy |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER |
| Intervention type | Drug |
| Interventions | Bortezomid (VELCADE®) |
| Enrollment | 46 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 30, 2006 |
| Last update posted | Feb 6, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: